Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 14/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 13/20 | 0.47 |
| ▸ | RAB9A | P51151 | 12/20 | 0.47 |
| ▸ | GAA | P10253 | 9/20 | 0.47 |
| ▸ | NPC1 | O15118 | 9/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.47 |
| ▸ | MEN1 | O00255 | 2/20 | 0.47 |
| ▸ | HPGD | P15428 | 7/20 | 0.47 |
| ▸ | GLA | P06280 | 7/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 7/20 | 0.45 |
| ▸ | POLB | P06746 | 2/20 | 0.45 |
| ▸ | MAPT | P10636 | 5/20 | 0.45 |
| ▸ | TP53 | P04637 | 1/20 | 0.45 |
| ▸ | GFER | P55789 | 2/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.40 |
| ▸ | CDC7 | O00311 | 1/20 | 0.39 |
| ▸ | DAPK3 | O43293 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13821060 | 0.97 | ALDH1A1 (0.47) | ALDH1A1KDM4ERAB9AGAANPC1 | |
| SCHEMBL13821066 | 0.97 | ALDH1A1 (0.48) | ALDH1A1KDM4ERAB9AGAANPC1 | |
| SCHEMBL13821079 | 0.95 | ALDH1A1 (0.50) | ALDH1A1KDM4ERAB9AGAANPC1 | |
| SCHEMBL13821061 | 0.94 | ALDH1A1 (0.53) | ALDH1A1KDM4ERAB9AGAANPC1 | |
| SCHEMBL13821053 | 0.94 | ALDH1A1 (0.52) | ALDH1A1KDM4ERAB9AGAANPC1 | |
| SCHEMBL13821048 | 0.93 | ALDH1A1 (0.54) | ALDH1A1KDM4ERAB9AGAANPC1 | |
| SCHEMBL13821045 | 0.93 | ALDH1A1 (0.54) | ALDH1A1KDM4ERAB9AGAANPC1 | |
| SCHEMBL13821059 | 0.93 | ALDH1A1 (0.49) | ALDH1A1KDM4ERAB9AGAANPC1 | |
| SCHEMBL13821046 | 0.93 | ALDH1A1 (0.46) | ALDH1A1KDM4ERAB9AGAANPC1 | |
| SCHEMBL13821054 | 0.93 | ALDH1A1 (0.51) | ALDH1A1KDM4ERAB9AGAANPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9012042-B2 | Condensed-cyclic compound, organic light-emitting device comprising the same, and flat panel display apparatus | SAMSUNG DISPLAY CO., LTD. (KR) | 2015-04-21 | — | — | US | disclosed |
| US-9012042-B2 | Condensed-cyclic compound, organic light-emitting device comprising the same, and flat panel display apparatus | SAMSUNG DISPLAY CO., LTD. (KR) | 2015-04-21 | — | — | US | disclosed |
| US-20120286246-A1 | CONDENSED-CYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING THE SAME, AND FLAT PANEL DISPLAY APPARATUS | SAMSUNG MOBILE DISPLAY CO., LTD. (KR) | 2012-11-15 | — | — | US | disclosed |
| US-20120286246-A1 | CONDENSED-CYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING THE SAME, AND FLAT PANEL DISPLAY APPARATUS | SAMSUNG MOBILE DISPLAY CO., LTD. (KR) | 2012-11-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120286246-A1 | CONDENSED-CYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING THE SAME, AND FLAT PANEL DISPLAY APPARATUS | OR10J3, AR, ARL1 | ALDH1A1 578/4885KDM4E 2875/4885RAB9A 1129/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.